CIK 2056786
Long positions in SEC Section 13(f) securities (US-listed stocks, ADRs and ETFs), largest first · Δ vs 2025-Q4. A lagged quarterly snapshot (filed ≤45 days after quarter-end); excludes shorts, options, cash, and shares listed only on non-US exchanges — foreign companies held via a US listing or ADR (e.g. Alibaba, TSMC) ARE included.
As filed = each book applied at its quarter-end (what the reported book did) · As copyable = applied at its statutory 45-day filing deadline (what a 13F follower could have earned).
Computing…
Hypothetical modeled performance constructed with hindsight — not actual results, and not indicative of future results. See the Disclaimer.
| Industry group | Weight | Names |
|---|---|---|
| Pharmaceuticals & Biotechnology | 47.80% | 2 |
| Software | 35.20% | 2 |
| Equity Real Estate Investment Trusts (REITs) | 16.33% | 1 |
| Unclassified | 0.67% | 1 |
| # | Ticker | Name | Sector | Weight |
|---|---|---|---|---|
| 1 | RVMD | Revolution Medicines, Inc. | Health Care | 44.36% |
| 2 | SAIL | SailPoint, Inc. | Information Technology | 33.00% |
| 3 | LINE | Lineage, Inc. | Real Estate | 16.33% |
| 4 | NMRA | Neumora Therapeutics, Inc. | Health Care | 3.44% |
| 5 | NAVN | Navan, Inc. | Information Technology | 2.20% |
| 6 | RVMDW | REVOLUTION MEDICINES INC | Unclassified | 0.67% |
5/6 names classified · sector 99.3% of weight · industry 99.3% · mkt cap 97.1%; unclassified names shown, never dropped.
Sector is classified on each name's CURRENT fundamentals, not point-in-time — apparent sector drift can reflect the market re-rating a holding, not a manager trade. 13F is a lagged quarterly snapshot of long positions in US-listed securities only — foreign companies held via a US listing or ADR ARE included, but shares listed only on non-US exchanges (plus shorts, options and cash) are not. Latest quarter: 99.3% of the book is sector-classified (unclassified names shown, never dropped).
Only 16% of book weight classified — the grid is NOT representative of the whole book.
Classified: 16.3% of book weight (1/6 names) · unclassified 83.7%: RVMD, SAIL, NMRA, NAVN, RVMDW. Size: cap 70/20/10 bands; style: value/growth composite on our own metrics — not Morningstar's model.
No contribution data for this period.
| Security | 2024-Q4 | 2025-Q1 | 2025-Q2 | 2025-Q3 | 2025-Q4 | 2026-Q1 | Latest value |
|---|---|---|---|---|---|---|---|
| RVMDREVOLUTION MEDICINES INC | — | 2.2M | 2.2M | 2.2M | 2.2M | 549K | $53M |
| SAILSAILPOINT INC | — | 3.0M | 3.0M | 3.0M | 3.0M | 3.0M | $40M |
| LINELINEAGE INC | — | 600K | 600K | 600K | 600K | 600K | $20M |
| NMRANEUMORA THERAPEUTICS INC. | — | 2.1M | 2.1M | 2.1M | 2.1M | 2.1M | $4M |
| NAVNNAVAN INC | — | — | — | — | 200K | 200K | $3M |
| RVMDWREVOLUTION MEDICINES INC | — | — | 450K | 450K | 450K | 450K | $805,500 |
Shares reported each quarter by the largest current holdings. Green = added vs the prior filing of that name, red = trimmed, grey = roughly held; a dash is a quarter with no 13F on file (a gap is skipped, not read as an exit). 13F is filed up to 45 days after quarter-end. Up to 40 quarters (10 years) available — use the selector above.
Where this firm's principals came from and which firms its alumni went on to found.
